Jan M Brauner
Overview
Explore the profile of Jan M Brauner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandkuhler J, Brochhagen S, Rohde P, Muscheidt R, Gromer T, Muller H, et al.
Depress Anxiety
. 2022 Aug;
39(12):760-769.
PMID: 35981135
Background: Seasonal affective disorder (SAD) is common and debilitating. The standard of care includes light therapy provided by a light box; however, this treatment is restrictive and only moderately effective....
2.
Leech G, Rogers-Smith C, Teperowski Monrad J, Sandbrink J, Snodin B, Zinkov R, et al.
Proc Natl Acad Sci U S A
. 2022 May;
119(23):e2119266119.
PMID: 35639701
The effectiveness of mask wearing at controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been unclear. While masks are known to substantially reduce disease transmission in healthcare settings...
3.
Schmidt S, Iuliano A, Vestergaard L, Mazagatos-Ateca C, Larrauri A, Brauner J, et al.
Influenza Other Respir Viruses
. 2022 Feb;
16(4):707-716.
PMID: 35194940
Background: Seasonal influenza-associated excess mortality estimates can be timely and provide useful information on the severity of an epidemic. This methodology can be leveraged during an emergency response or pandemic....
4.
Henerico S, Mikasi S, Kalluvya S, Brauner J, Abdul S, Lyimo E, et al.
J Antimicrob Chemother
. 2022 Feb;
77(2):483-491.
PMID: 35107140
Background: More than 15 million people in sub-Saharan Africa receive ART. Treatment failure is common, but the role of HIV drug resistance in treatment failure is largely unknown because drug...
5.
Mishra S, Mindermann S, Sharma M, Whittaker C, Mellan T, Wilton T, et al.
EClinicalMedicine
. 2021 Aug;
39:101064.
PMID: 34401689
Background: Since its emergence in Autumn 2020, the SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 (WHO label Alpha) rapidly became the dominant lineage across much of Europe. Simultaneously, several other VOCs...
6.
Brauner J, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenciak T, et al.
Science
. 2020 Dec;
371(6531).
PMID: 33323424
Governments are attempting to control the COVID-19 pandemic with nonpharmaceutical interventions (NPIs). However, the effectiveness of different NPIs at reducing transmission is poorly understood. We gathered chronological data on the...
7.
Rudovick L, Brauner J, Englert J, Seemann C, Plugaru K, Kidenya B, et al.
J Antimicrob Chemother
. 2018 Aug;
73(12):3476-3481.
PMID: 30165451
Background: In a 2008-10 study, we found a pretreatment HIV drug resistance (PDR) prevalence of 18.2% in patients at Bugando Medical Centre (BMC) in Mwanza, Tanzania. Objectives: To determine the...
8.
Jung J, Loy K, Schilling E, Rother M, Brauner J, Huth T, et al.
Mol Neurobiol
. 2017 Mar;
54(4):3117.
PMID: 28290148
No abstract available.
9.
Munoz L, Bilyy R, Biermann M, Kienhofer D, Maueroder C, Hahn J, et al.
Proc Natl Acad Sci U S A
. 2016 Sep;
113(40):E5856-E5865.
PMID: 27647892
The critical size for strong interaction of hydrophobic particles with phospholipid bilayers has been predicted to be 10 nm. Because of the wide spreading of nonpolar nanoparticles (NPs) in the...
10.
Rother M, Brauner J, Ebert K, Welzel O, Jung J, Bauereiss A, et al.
PLoS One
. 2014 Aug;
9(7):e102723.
PMID: 25079223
In compensatory endocytosis, scission of vesicles from the plasma membrane to the cytoplasm is a prerequisite for intravesicular reacidification and accumulation of neurotransmitter molecules. Here, we provide time-resolved measurements of...